Market Cap 176.12M
Revenue (ttm) 69.38M
Net Income (ttm) -20.58M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -29.66%
Debt to Equity Ratio 0.26
Volume 58,300
Avg Vol 83,474
Day's Range N/A - N/A
Shares Out 37.39M
Stochastic %K 61%
Beta -0.16
Analysts Sell
Price Target $6.83

Company Profile

EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology...

Industry: Medical Distribution
Sector: Healthcare
Phone: 33 4 72 15 31 50
Address:
Parc dActivites la Poudrette-Lamartine, 4/6, rue du DauphinE, Vaulx-En-Velin, France
finedge
finedge Feb. 23 at 3:28 PM
$EDAP Financial reporting has factored in 10 percent tariff prior and buyers have paid the additional cost. Sales continue to pace well and will result in the future earnings. Stay strong to the long term and as an opinionated guidance Hold and Buy for a strengthened inflection point targeted record highs. There is an HMO purchase in the horizon. Let’s go!
0 · Reply
finedge
finedge Feb. 23 at 2:54 PM
$EDAP snapped up at 4.40
0 · Reply
Georges8792
Georges8792 Feb. 23 at 7:10 AM
$EDAP https://www.linkedin.com/posts/nirav-bhatt-76b7b521_endometriosis-hifu-focalone-activity-7430864360937291776-HqGV?utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
mikegrand
mikegrand Feb. 23 at 3:36 AM
$EDAP https://youtu.be/DObcQVY4s5w?si=LTlNMNzzvR_d1t4l Interesting discussion in focal therapy, he mentions all the ongoing trials with HIFU and mentions the HIFUSA trial. I mentioned this trial awhile ago cause I was wanting an update and it seems it ends in June of this year and the preliminary results look good as it shows people that have HIFU early on instead of active surveillance have a 50% better chance of avoiding radical treatments down the line while still maintaining QoL That would be big if focal therapy takes place of active surveillance as a first line measure against most early cancers if you can avoid radical treatments downstream and would look good for insurances that want to prevent those costs down the line too
0 · Reply
Furderber
Furderber Feb. 20 at 4:24 PM
$EDAP SCOTUS decision may benefit EDAP eliminating tariffs. There are many positive developments for HIFU in US and ROW, and tranches minimize the risk of dilution. Updates on pipeline should be catalysts to $10 imho. Do your own DD.
0 · Reply
Georges8792
Georges8792 Feb. 20 at 7:59 AM
$EDAP https://www.linkedin.com/posts/cancer-prostatecancer-urology-ugcPost-7430276178839519232-Foxd?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
finedge
finedge Feb. 18 at 5:07 PM
$EDAP snapped up a few 😀
0 · Reply
finedge
finedge Feb. 18 at 3:41 PM
$EDAP nice entry point..
0 · Reply
ShadedFlicker
ShadedFlicker Feb. 18 at 8:06 AM
$EDAP EDAP TMS provides focused ultrasound for prostate cancer, facing surgeon training and reimbursement challenges [citation:historical].
0 · Reply
finedge
finedge Feb. 15 at 6:45 PM
$EDAP remarkable upcoming week. Focal Units sold, watch for HMO calibrating towards a proactive stance. Let’s go!
0 · Reply
Latest News on EDAP
EDAP Announces Appointment of David Horn to Board of Directors

Feb 12, 2026, 7:30 AM EST - 11 days ago

EDAP Announces Appointment of David Horn to Board of Directors


EDAP TMS S.A. (EDAP) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:26 PM EST - 3 months ago

EDAP TMS S.A. (EDAP) Q3 2025 Earnings Call Transcript


EDAP Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 7:30 AM EST - 3 months ago

EDAP Reports Third Quarter 2025 Financial Results


EDAP to Participate in the UBS Global Healthcare Conference

Oct 27, 2025, 7:00 AM EDT - 4 months ago

EDAP to Participate in the UBS Global Healthcare Conference


Focal One® HIFU Receives Prestigious Innovation Award

Sep 16, 2025, 7:00 AM EDT - 5 months ago

Focal One® HIFU Receives Prestigious Innovation Award


EDAP Receives HIFU Reimbursement for Prostate Cancer in France

Sep 8, 2025, 7:00 AM EDT - 6 months ago

EDAP Receives HIFU Reimbursement for Prostate Cancer in France


EDAP TMS S.A. (EDAP) Q2 2025 Earnings Conference Call Transcript

Aug 28, 2025, 12:25 PM EDT - 6 months ago

EDAP TMS S.A. (EDAP) Q2 2025 Earnings Conference Call Transcript


EDAP Reports Strong Second Quarter 2025 HIFU Results

Aug 28, 2025, 7:00 AM EDT - 6 months ago

EDAP Reports Strong Second Quarter 2025 HIFU Results


EDAP to Present at the Jefferies Global Healthcare Conference

May 27, 2025, 7:00 AM EDT - 9 months ago

EDAP to Present at the Jefferies Global Healthcare Conference


EDAP TMS S.A. (EDAP) Q1 2025 Earnings Call Transcript

May 15, 2025, 10:08 AM EDT - 10 months ago

EDAP TMS S.A. (EDAP) Q1 2025 Earnings Call Transcript


EDAP Reports First Quarter 2025 Financial Results

May 15, 2025, 7:00 AM EDT - 10 months ago

EDAP Reports First Quarter 2025 Financial Results


EDAP TMS S.A. (EDAP) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 11:56 AM EDT - 11 months ago

EDAP TMS S.A. (EDAP) Q4 2024 Earnings Call Transcript


EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results

Mar 27, 2025, 7:10 AM EDT - 11 months ago

EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results


EDAP Appoints Glen French to Board of Directors

Mar 3, 2025, 7:00 AM EST - 1 year ago

EDAP Appoints Glen French to Board of Directors

LUNG


EDAP Appoints Joshua H. Levine to Board of Directors

Jan 10, 2025, 7:00 AM EST - 1 year ago

EDAP Appoints Joshua H. Levine to Board of Directors


EDAP TMS S.A. (EDAP) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 9:16 PM EST - 1 year ago

EDAP TMS S.A. (EDAP) Q3 2024 Earnings Call Transcript


EDAP TMS S.A. (EDAP) Q2 2024 Earnings Call Transcript

Aug 28, 2024, 11:30 AM EDT - 1 year ago

EDAP TMS S.A. (EDAP) Q2 2024 Earnings Call Transcript


EDAP Reports Second Quarter 2024 Financial Results

Aug 28, 2024, 7:00 AM EDT - 1 year ago

EDAP Reports Second Quarter 2024 Financial Results


EDAP TMS (EDAP) Q1 2024 Earnings Call Transcript

May 16, 2024, 1:59 PM EDT - 1 year ago

EDAP TMS (EDAP) Q1 2024 Earnings Call Transcript


EDAP TMS (EDAP) Q4 2023 Earnings Call Transcript

Mar 27, 2024, 11:32 AM EDT - 2 years ago

EDAP TMS (EDAP) Q4 2023 Earnings Call Transcript


finedge
finedge Feb. 23 at 3:28 PM
$EDAP Financial reporting has factored in 10 percent tariff prior and buyers have paid the additional cost. Sales continue to pace well and will result in the future earnings. Stay strong to the long term and as an opinionated guidance Hold and Buy for a strengthened inflection point targeted record highs. There is an HMO purchase in the horizon. Let’s go!
0 · Reply
finedge
finedge Feb. 23 at 2:54 PM
$EDAP snapped up at 4.40
0 · Reply
Georges8792
Georges8792 Feb. 23 at 7:10 AM
$EDAP https://www.linkedin.com/posts/nirav-bhatt-76b7b521_endometriosis-hifu-focalone-activity-7430864360937291776-HqGV?utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
mikegrand
mikegrand Feb. 23 at 3:36 AM
$EDAP https://youtu.be/DObcQVY4s5w?si=LTlNMNzzvR_d1t4l Interesting discussion in focal therapy, he mentions all the ongoing trials with HIFU and mentions the HIFUSA trial. I mentioned this trial awhile ago cause I was wanting an update and it seems it ends in June of this year and the preliminary results look good as it shows people that have HIFU early on instead of active surveillance have a 50% better chance of avoiding radical treatments down the line while still maintaining QoL That would be big if focal therapy takes place of active surveillance as a first line measure against most early cancers if you can avoid radical treatments downstream and would look good for insurances that want to prevent those costs down the line too
0 · Reply
Furderber
Furderber Feb. 20 at 4:24 PM
$EDAP SCOTUS decision may benefit EDAP eliminating tariffs. There are many positive developments for HIFU in US and ROW, and tranches minimize the risk of dilution. Updates on pipeline should be catalysts to $10 imho. Do your own DD.
0 · Reply
Georges8792
Georges8792 Feb. 20 at 7:59 AM
$EDAP https://www.linkedin.com/posts/cancer-prostatecancer-urology-ugcPost-7430276178839519232-Foxd?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
finedge
finedge Feb. 18 at 5:07 PM
$EDAP snapped up a few 😀
0 · Reply
finedge
finedge Feb. 18 at 3:41 PM
$EDAP nice entry point..
0 · Reply
ShadedFlicker
ShadedFlicker Feb. 18 at 8:06 AM
$EDAP EDAP TMS provides focused ultrasound for prostate cancer, facing surgeon training and reimbursement challenges [citation:historical].
0 · Reply
finedge
finedge Feb. 15 at 6:45 PM
$EDAP remarkable upcoming week. Focal Units sold, watch for HMO calibrating towards a proactive stance. Let’s go!
0 · Reply
Georges8792
Georges8792 Feb. 13 at 10:15 AM
$EDAP https://www.linkedin.com/posts/hugoembert_medtech-hiring-cancer-activity-7427870187317612544-B5yB?utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_source=social_share_send&utm_campaign=share_via
1 · Reply
finedge
finedge Feb. 12 at 8:21 PM
$EDAP David Horn is known and solid towards future consolidation. Very excited, let’s go!
1 · Reply
Furderber
Furderber Feb. 12 at 2:24 PM
$EDAP Horn moves up to the Board. Came from Morgan Stanley. Notice Morgan Stanley has accumulated ~3M shares since he was onboarded. French out.
0 · Reply
Georges8792
Georges8792 Feb. 12 at 6:20 AM
$EDAP https://www.linkedin.com/posts/focal-one_usicon2026-cancer-prostatecancer-ugcPost-7427412581348306944-l50H?utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
topstockalerts
topstockalerts Feb. 11 at 4:44 PM
$EDAP Looks like it wants higher prices. Buyers keep stepping in. This trend is still alive 📈.
0 · Reply
JBird17
JBird17 Feb. 11 at 2:47 PM
$EDAP @mikegrand NCT06211933 for pancreatic tumor treatment changed in January from ‘Recruiting’ to ‘Active, not recruiting’. Noticed you asking about trials on yahoo. If you go to clinical trials. Gov you can search HIFU with France as the location and you can see everything being worked on or completed.
0 · Reply
Furderber
Furderber Feb. 10 at 6:47 PM
$EDAP Good volume today, 155k shares traded by around 1:43pm. I am pretty sure some who bought below $2 are reducing their exposure, but price is holding up. My target price is $15/share as it has been over the last 7 years....
0 · Reply
Georges8792
Georges8792 Feb. 10 at 4:56 PM
$EDAP https://www.linkedin.com/posts/jenny-robeson-3b0b024_high-intensity-ultrasound-treatment-activity-7427012047076470785-xf9C?utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
Georges8792
Georges8792 Feb. 9 at 4:26 PM
$EDAP https://www.linkedin.com/posts/satish-kumar-60a29026b_prostatecancer-robotichifu-focaltherapy-ugcPost-7426643442933460992--IRw?utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
finedge
finedge Feb. 9 at 3:03 PM
$EDAP margin capacity will increase at 30 day range at 5. Instituional leaps likely, let’s go as insiders hold for long term as not to drive share value down. Retail holders rewarded at 7 plus
1 · Reply
Georges8792
Georges8792 Feb. 8 at 6:12 PM
$EDAP https://www.linkedin.com/posts/dr-kalyan-kumar-thallapudi-7937971b5_oncology-aiinhealthcare-medicaltechnology-activity-7426286531855781888-ol78?utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
mikegrand
mikegrand Feb. 7 at 4:04 AM
$EDAP https://www.sciencedirect.com/science/article/abs/pii/S1078143926000037?dgcid=author So I found this study that shows the majority of the population doesn’t know that focal therapy is an option for pCa and that the r more educated/wealthy you are the more you know about the treatment option. There needs to be a focus on informing communities on this option, I ‘d say it’s the company’s job to do that but we need equal help from the hospitals that supply the option as they are beacons for the community.
0 · Reply